This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations in Lymphoma Treatment by Matthew Birrell
Introduction
Matthew Birrell is an accomplished inventor based in Lafayette, CA (US). He has made significant contributions to the field of oncology, particularly in the treatment of lymphoma. His innovative approach focuses on utilizing cerdulatinib, a promising compound for treating various types of lymphoma.
Latest Patents
Matthew Birrell holds 1 patent for his work titled "Methods for treating lymphoma." This patent outlines compositions and methods specifically designed for treating T-cell lymphoma and follicular lymphoma in human patients. The methods involve administering an effective amount of cerdulatinib, showcasing his commitment to advancing cancer treatment.
Career Highlights
Birrell is currently associated with Alexion Pharmaceuticals, Inc., a leading biopharmaceutical company known for its focus on rare diseases. His role at Alexion has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Matthew has worked alongside notable colleagues such as Gregory Coffey and Pamela B Conley. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.
Conclusion
Matthew Birrell's innovative work in lymphoma treatment exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for more effective therapies for patients battling lymphoma.